These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18328754)

  • 21. Consensus QSAR models: do the benefits outweigh the complexity?
    Hewitt M; Cronin MT; Madden JC; Rowe PH; Johnson C; Obi A; Enoch SJ
    J Chem Inf Model; 2007; 47(4):1460-8. PubMed ID: 17616180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9.
    Nembri S; Grisoni F; Consonni V; Todeschini R
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploiting QSAR models in lead optimization.
    Gedeck P; Lewis RA
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):569-75. PubMed ID: 18600573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applicability Domain: A Step Toward Confident Predictions and Decidability for QSAR Modeling.
    Kar S; Roy K; Leszczynski J
    Methods Mol Biol; 2018; 1800():141-169. PubMed ID: 29934891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A structure-information approach to the prediction of biological activities and properties.
    Hall LH
    Chem Biodivers; 2004 Jan; 1(1):183-201. PubMed ID: 17191786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing how well a modeling protocol captures a structure-activity landscape.
    Guha R; Van Drie JH
    J Chem Inf Model; 2008 Aug; 48(8):1716-28. PubMed ID: 18686944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relative Importance of Domain Applicability Metrics for Estimating Prediction Errors in QSAR Varies with Training Set Diversity.
    Sheridan RP
    J Chem Inf Model; 2015 Jun; 55(6):1098-107. PubMed ID: 25998559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative structure-activity relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation.
    Basak SC; Mills D; Hawkins DM; Kraker JJ
    Chem Biodivers; 2009 Apr; 6(4):487-502. PubMed ID: 19353545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals.
    Matthews EJ; Kruhlak NL; Daniel Benz R; Ivanov J; Klopman G; Contrera JF
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):136-55. PubMed ID: 17175082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination and prediction of xenoestrogens by recombinant yeast-based assay and QSAR.
    Li F; Chen J; Wang Z; Li J; Qiao X
    Chemosphere; 2009 Mar; 74(9):1152-7. PubMed ID: 19136139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicals.
    Fratev F; Benfenati E
    J Mol Graph Model; 2008 Sep; 27(2):147-60. PubMed ID: 18495507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid toxicity prediction of organic chemicals to Chlorella vulgaris using quantitative structure-activity relationships methods.
    Xia B; Liu K; Gong Z; Zheng B; Zhang X; Fan B
    Ecotoxicol Environ Saf; 2009 Mar; 72(3):787-94. PubMed ID: 18950860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis.
    Gleeson MP
    J Med Chem; 2007 Jan; 50(1):101-12. PubMed ID: 17201414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized heuristic inverse quantitative structure activity relationship with bulk descriptors using numerical gradients.
    Stålring J; Almeida PR; Carlsson L; Helgee Ahlberg E; Hasselgren C; Boyer S
    J Chem Inf Model; 2013 Aug; 53(8):2001-17. PubMed ID: 23845139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.
    Viña D; Uriarte E; Orallo F; González-Díaz H
    Mol Pharm; 2009; 6(3):825-35. PubMed ID: 19281186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of MOLMAP approach for QSAR modeling of various biological activities using substituent electronic descriptors.
    Hemmateenejad B; Mehdipour AR; Miri R; Shamsipur M
    J Comput Chem; 2009 Oct; 30(13):2001-9. PubMed ID: 19130500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
    Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
    J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward robust QSPR models: Synergistic utilization of robust regression and variable elimination.
    Grohmann R; Schindler T
    J Comput Chem; 2008 Apr; 29(6):847-60. PubMed ID: 17963234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.